Delineating the role of IL-31 in the pathophysiology of Prurigo Nodularis

Time: 12:10 pm
day: Day 2 AM - Track A


  • Shining light on the molecular and cellular characterization of PN
  • Scientifically rationalizing the investigation of IL-31 in PN
  • Highlighting the mechanism of action of the anti-IL-31RA drug, nemolizumab in PN using a multi-omics approach